Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01901783 · ClinicalTrials.gov registry record · NA

Ridge Augmentation Without Primary Closure

A NA study, sponsored by University of Louisville.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT01901783 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01901783, a NA study, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

This study is designed to compare the clinical and histologic results of ridge augmentation with and without primary closure over the barrier membrane. The hypothesis is that there will be no difference in crestal ridge width between the two groups.

Interventions

  • PROCEDURE With primary closure
  • PROCEDURE Without primary closure

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2013-09
Est. Completion 2014-06
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT01901783

The ClinicalTrials.gov registry entry for NCT01901783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which With primary closure is the first listed.

NCT01901783 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01901783 about?

NCT01901783 is a clinical study titled "Ridge Augmentation Without Primary Closure". This study is designed to compare the clinical and histologic results of ridge augmentation with and without primary closure over the barrier membrane. The hypothesis is that there will be no difference in crestal ridge width between the two groups.

What is the current status of trial NCT01901783?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2013-09. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01901783?

The interventions under investigation include: With primary closure (PROCEDURE), Without primary closure (PROCEDURE).

Who is sponsoring clinical trial NCT01901783?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.